WakeMed Cancer Care - Waverly Hematology & Medical Oncology — Cary, North Carolina

WakeMed Cancer Care - Waverly Hematology & Medical Oncology is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

WakeMed Cancer Care - Waverly Hematology & Medical Oncology has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Solid Tumors, Hematologic Malignancies.

Sponsors: Eli Lilly and Company, Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cary

Browse all research sites in North Carolina · View every site in Cary

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for WakeMed Cancer Care - Waverly Hematology & Medical Oncology?

WakeMed Cancer Care - Waverly Hematology & Medical Oncology has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has WakeMed Cancer Care - Waverly Hematology & Medical Oncology conducted?

WakeMed Cancer Care - Waverly Hematology & Medical Oncology has 3 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Solid Tumors, Hematologic Malignancies.

Is WakeMed Cancer Care - Waverly Hematology & Medical Oncology accredited by Crixeo Clinical Trials?

WakeMed Cancer Care - Waverly Hematology & Medical Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about WakeMed Cancer Care - Waverly Hematology & Medical Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.